title: Silent thalassemias: genotypes and phenotypes.
abstract: OBJECTIVE
  Current application of molecular biology techniques to the study of the DNA of globin genes has confirmed the existence of silent alpha and beta thalassemias; which had already been reported on the basis of red blood cell parameters and family studies. The present work was aimed at analyzing all the aspects of the phenotype of the most common varieties of silent thalassemia.
  
  
  METHODS
  Groups of heterozygous carriers of these varieties were examined using established techniques that determined all hematologic, hemoglobin (electrophoresis and measurement of Hb A2 and Hb F levels), and globin synthesis (evaluation of the alpha/beta ratio) parameters. Furthermore, all subjects underwent a complete molecular study of the alpha and beta globin genes by means of the ARMS, SSCP, DGGE, PCR and Southern blotting techniques.
  
  
  RESULTS
  1) The -101 C-->T mutation of the promoter of the beta globin gene shows a normal hematological picture with the Hb A2 level often slightly raised and the alpha/beta globin synthesis ratio slightly greater than 1; 2) beta + thalassemia resulting from the IVS II 844 C-->G mutation has a phenotype that is even closer to normal; 3) -alpha 3.7 deletion type I usually has a totally silent phenotype; 4) the alpha Ncol mutation almost always gives rise to a sub-silent phenotype if it is located on gene alpha 2 and to a silent phenotype if it is found on gene alpha 1; 5) alpha + thalassemia due to the alpha 2 Hphl mutation displays a sub-silent phenotype in some cases and a silent one in others; 6) triplication of the alpha genes gives rise to a phenotype that is quite similar to that of the -101 C-->T mutation of the promoter of the beta globin gene, namely one that is very often silent.
  
  
  CONCLUSIONS
  Many of these silent varieties (beta + thalassemia due to the -101 C-->T mutation; alpha + thalassemia from a deletion or point mutation of an alpha gene; alpha alpha alpha triplication) are quite frequent in the overall group of thalassemias. It is therefore important for the operators in the field of thalassemia diagnosis to possess exact knowledge of them especially in order to prevent thalassemia major.
authors.affiliation: Associatione Nazionale per la lotta contro le Microcitemie in Italia, Rome, Italy.
authors.forename: I
authors.initials: I
authors.lastname: Bianco
authors.forename: M P
authors.initials: MP
authors.lastname: Cappabianca
authors.forename: E
authors.initials: E
authors.lastname: Foglietta
authors.forename: M
authors.initials: M
authors.lastname: Lerone
authors.forename: G
authors.initials: G
authors.lastname: Deidda
authors.forename: L
authors.initials: L
authors.lastname: Morlupi
authors.forename: P
authors.initials: P
authors.lastname: Grisanti
authors.forename: D
authors.initials: D
authors.lastname: Ponzini
authors.forename: S
authors.initials: S
authors.lastname: Rinaldi
authors.forename: B
authors.initials: B
authors.lastname: Graziani
mesh_terms: D000293:Adolescent; D000328:Adult; D015139:Blotting, Southern; D002648:Child; D004252:DNA Mutational Analysis; D005260:Female; D017353:Gene Deletion; D005796:Genes; D006580:Genetic Carrier Screening; D018740:Genetic Heterogeneity; D005838:Genotype; D005914:Globins / Q000235:genetics*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D017354:Point Mutation; D016133:Polymerase Chain Reaction; D018807:Polymorphism, Single-Stranded Conformational; D013789:Thalassemia / Q000235:genetics* / Q000473:pathology
chemical_list: D005914:Globins